MDxHealth is trading 5.01% down at $0.72 as healthcare stocks and broader U.S. markets sell off.
- No new company-specific announcement was identified on August 20, 2026.
- The latest material update was the August 13 second-quarter report, which included 16% revenue growth and reaffirmed 2026 guidance; the decline therefore appears driven mainly by sector rotation and risk-off sentiment rather than fresh company news.